Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02417688 · ClinicalTrials.gov registry record · Phase 1
PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis
A Phase 1 study of Carotid Atherosclerosis, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 1
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT02417688: Completed Phase 1 study of Carotid Atherosclerosis, sponsored by Washington University School of Medicine.
NCT02417688 is a Phase 1 study of Carotid Atherosclerosis that has completed, run by Washington University School of Medicine. The registered enrollment target is 44 participants, below the 164-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (73% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02417688, a Phase 1 study of Carotid Atherosclerosis, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
To demonstrate feasibility of imaging Cu\[64\]-25%-CANF-Comb uptake in the atherosclerosis of the carotid artery of patients for whom carotid artery endarterectomy surgery is planned in comparison to the carotid artery for which intervention is not planned.
Primary Outcome
Difference in SUV between the carotid with atherosclerosis (carotid artery to be undergo surgery) and the carotid artery without significant disease (artery for which surgery is not planned).
Conditions Studied
Interventions
- DEVICE Cu[64]-25%-CANF-Comb PET-MR
Study Locations (1)
Missouri
- Washington University in St.Louis - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2015-04-05 |
| Est. Completion | 2021-04-30 |
| Phase | Phase 1 |
What the finished NCT02417688 record still lists
NCT02417688 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 164-participant average among 5 other Carotid Atherosclerosis trials with a reported enrollment target (73% lower).
The record links to 1 condition, with Carotid Atherosclerosis appearing as the primary indexed condition, and to 1 intervention - of which Cu[64]-25%-CANF-Comb PET-MR is the first listed.
NCT02417688 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT02417688 about?
NCT02417688 is a clinical study titled "PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis". To demonstrate feasibility of imaging Cu\[64\]-25%-CANF-Comb uptake in the atherosclerosis of the carotid artery of patients for whom carotid artery endarterectomy surgery is planned in comparison to the carotid artery for which intervention is not planned.
What is the current status of trial NCT02417688?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 44 participants. The study started on 2015-04-05. Estimated completion is 2021-04-30.
What conditions does trial NCT02417688 study?
This clinical trial studies the following conditions: Carotid Atherosclerosis.
What interventions are being tested in trial NCT02417688?
The interventions under investigation include: Cu[64]-25%-CANF-Comb PET-MR (DEVICE).
Who is sponsoring clinical trial NCT02417688?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02417688 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carotid Atherosclerosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
PET Detection of CCR2 in Human Atherosclerosis
RECRUITING · Phase 1
-
Potential Risk Factors for Stroke
COMPLETED · Phase 1
-
CANF-Comb-II PET-MR in Atherosclerosis Multisite
RECRUITING
-
Risk Assessment of Carotid Plaques Using 3D Contrast-Enhanced Ultrasound
ACTIVE NOT RECRUITING · Phase 4
-
Comparison of Asymptomatic Carotid Atherosclerosis Between Frequent and Infrequent Blood Donors
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI